Cargando…

High expression of RPL27A predicts poor prognosis in patients with hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers in the digestive system with rapid progression and poor prognosis. Recent studies have shown that RPL27A could be used as a biomarker for a variety of cancers, but its role in HCC is not clear. METHOD: We analyzed the expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Huiwu, Jiang, Xiangqi, Yang, Chenyu, Tan, Bingqian, Hu, Jiqiang, Zhang, Mingman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360225/ https://www.ncbi.nlm.nih.gov/pubmed/37474947 http://dx.doi.org/10.1186/s12957-023-03102-w

Ejemplares similares

Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study
por: Xing, Huiwu, et al.
Publicado: (2022)

Immune Characteristics in Biliary Atresia Based on Immune Genes and Immune Cell Infiltration
por: Yang, Chenyu, et al.
Publicado: (2022)

Competitive risk analysis of the therapeutic value of liver transplantation for liver cancer in children: A population-based study
por: Xing, Huiwu, et al.
Publicado: (2022)

A sewing needle in the liver in children: A case report and literature review
por: Xing, Huiwu, et al.
Publicado: (2022)

Learning Curve Analysis of Microvascular Hepatic Artery Anastomosis for Pediatric Living Donor Liver Transplantation: Initial Experience at A Single Institution
por: Zhou, Wanyi, et al.
Publicado: (2022)

Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
por: Yang, Chenyu, et al.
Publicado: (2022)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
por: Li, Songwei, et al.
Publicado: (2021)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2020)

Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
por: Tan, Xiaolong, et al.
Publicado: (2018)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
por: Rao, Shuyun, et al.
Publicado: (2019)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma
por: Jiang, Qingping, et al.
Publicado: (2013)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma
por: Zhang, Chunfeng, et al.
Publicado: (2022)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2019)

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
por: Ruan, Jian, et al.
Publicado: (2016)

Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma
por: Shao, Xian, et al.
Publicado: (2018)

Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aq757sdv6sh95rbjk7l67247aq